Search

Search Constraints

You searched for: Author/Creator Schippling, Sven

Search Results

1. A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis. (December 2021)

3. Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy. (12th September 2017)

4. Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings. (12th September 2017)

5. ALEMTUZUMAB PERSISTENTLY SLOWS BRAIN VOLUME LOSS IN RRMS. Issue 12 (15th November 2016)

6. APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies. (13th July 2021)

7. Automated detection of hyperreflective foci in the outer nuclear layer of the retina. Issue 2 (8th September 2022)

9. Diagnostic red flags: steroid‐treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination. (6th April 2017)

10. How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis. (April 2020)